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A rapid headspace-gas chromatography (HS-GC) method was developed for the analysis of ethylene glycol and
propylene glycol in plasma and serum specimens using 1,3-propanediol as the internal standard. The method
employed a single-step derivitization using phenylboronic acid, was linear to 200 mg/dL and had a lower limit of
quantitation of 1 mg/dL suitable for clinical analyses. The analytical method described allows for laboratories with
HS-GC instrumentation to analyze ethanol, methanol, isopropanol, ethylene glycol, and propylene glycol on a single
instrument with rapid switch-over from alcohols to glycols analysis. In addition to the novel HS-GC method, a
retrospective analysis of patient specimens containing ethylene glycol and propylene glycol was also described. A
total of 36 patients ingested ethylene glycol, including 3 patients who presented with two separate admissions for
ethylene glycol toxicity. Laboratory studies on presentation to hospital for these patients showed both osmolal and
anion gap in 13 patients, osmolal but not anion gap in 13 patients, anion but not osmolal gap in 8 patients, and 1
patient with neither an osmolal nor anion gap. Acidosis on arterial blood gas was present in 13 cases. Only one
fatality was seen; this was a patient with initial serum ethylene glycol concentration of 1282 mg/dL who died on
third day of hospitalization. Propylene glycol was common in patients being managed for toxic ingestions, and was
often attributed to iatrogenic administration of propylene glycol-containing medications such as activated charcoal
and intravenous lorazepam. In six patients, propylene glycol contributed to an abnormally high osmolal gap. The
common presence of propylene glycol in hospitalized patients emphasizes the importance of being able to identify
both ethylene glycol and propylene glycol by chromatographic methods.
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Consumption of ethylene glycol continues to be a public
health problem (Kraut & Kurtz 2008). Ethylene glycol is
most commonly found in automobile antifreeze. Ethylene
glycol is metabolized by a series of steps to glycolic acid,
glyoxylic acid, and finally oxalic acid, the latter with the
potential to cause severe renal injury (Barceloux et al. 1999;
Jammalamadaka & Raissi 2010). The definitive laboratory
method for detection and quantitation of ethylene glycol in
the serum/plasma is gas chromatography (GC), preferably
with mass spectrometric detection (GC/MS) (Wu et al.
1995). Rapid enzymatic assays for ethylene glycol are
available and have been used in the veterinary setting* Correspondence: mkrasows@healthcare.uiowa.edu
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in any medium, provided the original work is p(Malandain & Cano 1996). However, these rapid assays
suffer from lack of specificity, particularly cross-reactivity
with chemically related compounds such as propylene
glycol and 2,3-butanediol, although recent progress has
been made in improving specificity (Juenke et al. 2011).
Indirect measures of ethylene glycol ingestion include
osmolal and anion gap, both of which may be elevated in
ethylene glycol and methanol ingestions (Krasowski et al.
2012; Lynd et al. 2008). However, osmolal gap elevation is
not specific to toxic alcohol or glycol ingestion, with osmo-
lal gap elevations seen in diabetic ketoacidosis, alcohol
ketoacidosis, renal failure, shock, and recent mannitol infu-
sion (Krasowski et al. 2012; Lynd et al. 2008; Almaghamsi
& Yeung 1997; Braden et al. 1993; Dursun et al. 2007;
Garcia-Morales et al. 2004; Gill et al. 2005; Guglielminotti
et al. 2002; Huff 1990; Sklar & Linas 1983).n Open Access article distributed under the terms of the Creative Commons
g/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction
roperly cited.
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col and is also used in some automobile antifreezes
(Kraut & Kurtz 2008; Zar et al. 2007). Propylene glycol
is generally much less toxic than ethylene glycol and is
found in a variety of products including beverages, cos-
metics, ointments, activated charcoal preparations, and
as a diluent for intravenous preparations of poorly
water-soluble drugs such as diazepam, etomidate, and
lorazepam. Propylene glycol toxicity has been described
in overdoses of propylene glycol-containing antifreeze
(Brooks & Wallace 2002). A number of studies have
detailed propylene glycol toxicity from repeated intravenous
administrations of medications containing propylene glycol
as the diluent, particularly lorazepam used for extended
sedation (e.g., intubated patients on mechanical ventilation)
(Al-Khafaji et al. 2002; Arbour 1999; Chicella et al. 2002;
Parker et al. 2002; Wilson et al. 2005).
In this study, we describe a rapid HS-GC method for
simultaneous quantitation of ethylene glycol and propylene
glycol in human serum and plasma samples. Previous stud-
ies have reported GC (Balikova & Kohlicek 1988; Houze
et al. 1993; Porter & Auansakul 1982; Smith 1984) methods
with liquid injections for ethylene glycol. More recently, a
GC-MS method has been described for ethylene glycol
determination (Porter & Rutter 2010); however, many
clinical laboratories do not have access to GC-MS instru-
mentation. The method we describe utilizes HS-GC instru-
mentation commonly used for measurement of ethanol,
methanol, acetone, and isopropanol (‘toxic alcohols’) and
allows for HS-GC for the toxic alcohols, ethylene glycol,
and propylene glycol. The relatively high boiling points of
ethylene glycol (197°C) and propylene glycol (188°C)
necessitate derivatization prior to HS-GC. We utilize a
simple derivitization step with phenylboronic acid prior to
HS-GC, adapting from the original phenylboronic acid GC
liquid injection method (Porter & Auansakul 1982). We
also present a retrospective analysis into determination of
ethylene glycol and propylene glycol in specimens at an
academic medical center central clinical laboratory.
Experimental
Reagents and materials
Ethylene glycol was obtained from Fisher Scientific
(Pittsburgh, PA, USA). 1,2-Propanediol (propylene glycol),
1,3-propanediol, acetone (HPLC grade), 2,3-butanediol,
diethylene glycol, and phenylboronic acid were all obtained
from Sigma-Aldrich (St Louis, MO, USA). Lyphochek Drug
Free Serum was obtained from Bio-Rad (Hercules, CA,
USA). HPLC grade deionized water was prepared in-house.
A glycol stock standard was prepared to contain ethylene
glycol and propylene glycol both at a concentration of
1000 mg/dL in drug free serum. Additional working
standards were prepared by diluting the stock standard with
drug free serum to obtain concentrations of 200 mg/dL,100 mg/dL, 50 mg/dL and 10 mg/dL. An internal
standard solution was prepared by adding 75 μL of
1,3-propanediol to 100 mL HPLC grade deionized
water (concentration ~79.5 mg/dL). A 5 mg/mL solution of
phenylboronic acid was prepared in HPLC grade acetone.
HS-GC analysis
The GC system consisted of a PerkinElmer (Waltham, MA,
USA) Clarus 580 GC with a PerkinElmer TurboMatrix 40
headspace sampler. The Clarus 580 was equipped with a
flame ionization detector and an Elite 200 capillary column
(PerkinElmer). To 50 μL of sample (standard, control, or
patient sample) in a small TDX centrifuge tube, 50 μL of
the 1,3-propanediol internal standard solution, and 200 μL
of the phenylboronic acid in acetone solution were added.
The samples were vortexed for 5 seconds and centrifuged
at 13,200 RPM for 1 minute to remove precipitated
proteins. 10 μL of the supernatant was transferred to a
headspace vial, sealed, and placed on the TurboMatrix 40.
Vials were thermostatted for 9 minutes in a 140°C
oven before injecting for 0.02 minutes onto the GC
for analysis. The headspace needle and transfer line
were at 180°C and 205°C, respectively, with the transfer
line pressure set at 40 psi.
The GC oven was temperature programmed with an
initial temperature of 80°C, increasing to 120°C at a rate
of 20°C/minute, followed by an increase to 300°C at a rate
of 45°C/minute with a hold at 300°C for 0.5 minutes.
The temperature program was extensively optimized
to decrease analysis time while maintaining good peak
separation and preventing contamination of the column to
allow detection of toxic alcohols (ethanol, methanol, iso-
propanol) on the same column. GC injector and detector
temperatures were both set at 250°C. The method could be
switched from toxic alcohol to glycols analysis within
2 minutes.
Retrospective analysis
We have previously presented a large retrospective study
of toxic alcohol and glycol analysis in patient samples at
an academic medical center (Krasowski et al. 2012). In
this study, we focus on the subset of 153 patients where
GC analysis for ethylene glycol and propylene glycol was
performed. Osmolal gap was calculated using a formula
by Khajuria and Krahn (2005): osmolal gap = (Measured
osmolality) – {2 x [Sodium] + (1.15 * [Glucose]/18) +
([BUN]/2.8) + (1.2 * [ETOH]/4.6), where [Sodium] is plasma
sodium concentration in mEq/L, [Glucose] is plasma
glucose concentration in mg/dL, [BUN] is plasma blood
urea nitrogen in mg/dL, and [ETOH] is plasma ethanol
concentration in mg/dL. Anion gap was equal to the plasma
sodium concentration minus the sum of plasma bicarbon-
ate and chloride concentrations (all measured in mEq/L).
At the medical center clinical laboratory, 15 or greater was
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laboratory measurements were performed in the central
Clinical Chemistry laboratory. Serum/plasma electrolytes,
BUN, glucose, and ethanol were determined on high
volume chemistry analyzers (Roche P modules, Roche
Diagnostics, Inc., Indianapolis, IN, USA). Serum/plasma
osmolality was determined by freezing point depression
(Model 2020 osmometer, Advanced Instruments, Inc.,
Norwood, MA, USA). The project had Institutional Review
Board approval from the University of Iowa.
Results and discussion
Under the described conditions, the retention times of
ethylene glycol, propylene glycol and 1,3-propanediol
(internal standard) were 2.45, 2.52, and 3.05 minutes,
respectively (Figure 1). This method was linear from a
range of 1 mg/dL to 200 mg/dL for ethylene glycol and
10 mg/dL to 200 mg/dL for propylene glycol (Figure 2),
with a correlation of r2 = 0.99 achievable for both ethylene
glycol and propylene glycol. It is well established that
ethylene glycol plasma concentrations do not always
correlate with clinical severity (Porter 2012), with
cases of severe toxicity described with ethylene glycol
in the 5–10 mg/dL range (Rosano et al. 2009; Moreau
et al. 1998; Porter et al. 2001). Patients that present
many hours after ingestion are at particular risk for
severe toxicity and renal damage (Porter 2012). Intra
and inter-day precision and accuracy at ethylene glycol
and propylene glycol concentrations of 25 mg/dL are
summarized in Table 1.
No interference was detected from 2,3-butanediol,
diethylene glycol (Williams et al. 2000), or from
patients with elevated levels of ethanol. Numerous
samples from patients presenting to the emergency
room (the typical patient population requiring rapid
glycol analysis) were tested to check for interfering
peaks, with none detected. Serum and plasma speci-
mens were both acceptable, including from EDTA
anticoagulated tubes and plasma separator tubes
using lithium heparin as anticoagulant.
Retrospective analysis of ethylene glycol ingestions
In a retrospective analysis of samples analyzed at the
hospital core Clinical Chemistry laboratory, a total of 36
patients were found to have detectable ethylene glycol in
plasma/serum. Three patients presented with two separate
admissions for ethylene glycol toxicity. A summary of these
patients is found in Additional file 1. There was only one
fatality. This occurred in a patient with an estimated inges-
tion of 1 gallon of antifreeze who presented with a plasma
ethylene glycol concentration of 1282 mg/dL. Two patients
survived ingestions that resulted in ethylene glycol concen-
trations exceeding 800 mg/dL; one of these patients
was in coma for 7 days and ultimately spent 33 dayson an inpatient unit prior to discharge. Thirty-five
patients had laboratory studies sufficient to calculate
both osmolal and anion gaps. Of these 35 patients, 13
had both osmolal and anion gaps, 13 had only an
osmolal gap, 8 had only an anion gap, and 1 had
neither an osmolal nor anion gap.
All but two ingestions were deliberate self-harm
attempts. Of the two non-self-harm attempts, one was
an ingestion based on someone else passing antifreeze
off as an ethanolic drink; the other was a teenager
ingesting antifreeze in a misguided effort to achieve
intoxication. Arterial blood gas analysis was performed in
25 cases; acidosis (pH < 7.35) was seen in 13 of these
cases. Ethanol was detected in 13 of 36 cases, in 3
cases with plasma ethanol concentrations exceeding
200 mg/dL. It is likely in some cases that prior
consumption of ethanol provided some degree of
protection from ethylene glycol ingestion due to
inhibition of metabolism by alcohol dehydrogenase.
Propylene glycol was detected in 5 cases (discussed in
more detail below).
Detection of propylene glycol in patient samples
We detected propylene glycol at a plasma concentration
of 10.0 mg/dL or greater in a total of 30 patients
(37 total measurements). The most common presen-
tation in these patients was drug overdose or toxic
ingestion including acetaminophen overdose (6 patients),
ethylene glycol ingestion (6 patients), prescription drug
overdose (4 patients), and ingestion of unknown substances
(3 patients). Five patients presented with suspected ethanol
withdrawal. A summary of these patients is found in
Additional file 2. Chart review identified likely iatrogenic
sources of propylene glycol in 22 patients (intravenous
lorazepam – 15 patients; intravenous diazepam – 1 patient;
activated charcoal – 6 patients). Additional file 2 also
indicates the estimated contribution of the plasma
propylene glycol to the osmolal gap, using the propyl-
ene glycol concentration (in mg/dL) divided by 7.2
(Zar et al. 2007). In six of the patients, the estimated
contribution of propylene glycol to the osmolal gap
was necessary in reaching an osmolal gap cutoff of
15, which was the level of osmolal gap deemed abnormal
at the medical center.
Implications for toxicology analysis
The HS-GC method presented here provides rapid
quantitation of ethylene glycol and propylene glycol in
human plasma or serum. The instrumentation is the same
as that used for HS-GC measurements of ethanol and ‘toxic
alcohols’ such as methanol and isopropanol, allowing for
use of a single HS-GC analyzer for determination of plasma
concentrations of toxic alcohols and glycols. HS-GC
analysis of the glycols, even following derivitization, does
Figure 1 HS-GC separation of the phenylboronic derivatives of ethylene glycol (EG) and propylene glycol (PG) with 1,3-propanediol as
the internal standard (IS). (A) Quality control plasma sample containing 25 mg/dL each of EG and PG. (B) Patient plasma sample containing
11.6 mg/dL of EG. (C) Patient plasma sample containing 53.4 mg/dL of PG.
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the lower vapor pressure and higher boiling points
of the phenylboronic derivatives of ethylene and pro-
pylene glycol compared to the alcohols. HS-GC of
underivitized ethylene and propylene glycol is likely
possible but would require headspace temperatureshigher than typically possible for most commercial
headspace units.
Clinical importance of propylene glycol
The results presented here indicate that detection of
propylene glycol is common in hospital patients,
Figure 2 Linearity plots of HS-GC analysis of ethylene glycol
and propylene glycol. A Linearity of ethylene glycol and propylene
glycol shown using linear y-axis. B Linearity of ethylene glycol using
a logarithmic y-axis for broader view of linearity of method for
measurement of ethylene glycol concentrations.
Table 1 Accuracy and precision studies
Ethylene glycol Propylene glycol
Nominal concentration (mg/dL) 25 25
Intra-day mean (n = 5) 25.9 ± 0.4 25.8 ± 0.2
Intra-day CV 1.47% 0.86%
Inter-day (n = 15) mean 25.8 ± 0.3 25.7 ± 0.3
Inter-day CV 1.16% 1.32%
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other toxic ingestions. The major source of propylene
glycol comes from iatrogenic administration of poorly
water-soluble medications, especially intravenous
lorazepam used for sedation. Intravenous formulations
of lorazepam may contain up to 80% (v/v) propylene
glycol. Other intravenous medications that may con-
tain propylene glycol include diazepam, etomidate,
and phenytoin (Al-Khafaji et al. 2002; Arbour 1999;
Chicella et al. 2002; Parker et al. 2002). Another
source of propylene glycol is activated charcoal prepa-
rations that use propylene glycol as the excipient to
make the charcoal less gritty and easier to administer(Krasowski et al. 2012). Although the toxic plasma
concentration of propylene glycol is not well-defined,
toxicity has been reported with plasma concentrations
as low as 100 mg/dL (Zar et al. 2007). However, even
if not directly toxic, propylene glycol increases plasma
osmolality and complicates the use of osmolal gap in
clinical diagnosis and management, especially for
patients receiving multiple doses of propylene glycol-
containing medication, as may be done in intubated
patients requiring extended sedation (Krasowski et al.
2012). Propylene glycol has also been reported as an
interferent in enzyme assays for ethylene glycol
(Malandain & Cano 1996; Juenke et al. 2011). Our study
demonstrates that propylene glycol may be detected in pa-
tients who have ingested ethylene glycol, with iatrogenic
drugs such as intravenous lorazepam or activated charcoal
being common sources of propylene glycol. These find-
ings illustrate the importance of specific assays for
determination of ethylene glycol in human samples.Clinical importance of chromatographic methods for
ethylene glycol
The retrospective study performed illustrates the
importance of having a specific method for ethylene
glycol. The majority of cases had either an osmolal
gap or anion gap or both; however, in a number of
patients, these gaps were only slightly elevated and 1
patient presented without either an osmolal or anion
gap. In addition, 13 cases presented with co-ingestion
of ethanol. Intravenous ethanol was used as treatment
in 8 cases as well. Chromatographic analysis thus
continues to play important role in detecting and
managing ethylene glycol intoxications.Additional files
Additional file 1: Clinical history and laboratory data on patients
with ethylene glycol ingestions.
Additional file 2: Clinical history and laboratory data on patients
with propylene glycol plasma concentration of 10 mg/dl or greater.Competing interests
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